These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 20680187)

  • 1. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
    Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
    Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses.
    Gill HS; DeVane CL; Risch SC
    J Clin Psychopharmacol; 1997 Oct; 17(5):377-89. PubMed ID: 9315989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain and antidepressants.
    Fava M
    J Clin Psychiatry; 2000; 61 Suppl 11():37-41. PubMed ID: 10926053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Withdrawal symptoms of antidepressants].
    Vlaminck JJ; van Vliet IM; Zitman FG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):698-701. PubMed ID: 15819135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems with currently available antidepressants.
    Gumnick JF; Nemeroff CB
    J Clin Psychiatry; 2000; 61 Suppl 10():5-15. PubMed ID: 10910012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-induced hepatotoxicity.
    Lucena MI; Carvajal A; Andrade RJ; Velasco A
    Expert Opin Drug Saf; 2003 May; 2(3):249-62. PubMed ID: 12904104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapyramidal Reactions Associated with Serotonergic Antidepressants.
    Hawthorne JM; Caley CF
    Ann Pharmacother; 2015 Oct; 49(10):1136-52. PubMed ID: 26185277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of antidepressants in the elderly.
    Sommer BR; Fenn H; Pompei P; DeBattista C; Lembke A; Wang P; Flores B
    Expert Opin Drug Saf; 2003 Jul; 2(4):367-83. PubMed ID: 12904093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
    Machado M; Iskedjian M; Ruiz I; Einarson TR
    Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
    Arnold LM
    Pain Med; 2007 Sep; 8 Suppl 2():S63-74. PubMed ID: 17714117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac disorders and antidepressant medications.
    Murray JB
    J Psychol; 2000 Mar; 134(2):162-8. PubMed ID: 10766108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance programme.
    Mörkl S; Seltenreich D; Letmaier M; Bengesser S; Wurm W; Grohmann R; Bleich S; Toto S; Stübner S; Butler MI; Kasper S
    World J Biol Psychiatry; 2020 Apr; 21(4):308-316. PubMed ID: 31347932
    [No Abstract]   [Full Text] [Related]  

  • 17. Contemporary management of depression.
    Andrews JM; Nemeroff CB
    Am J Med; 1994 Dec; 97(6A):24S-32S. PubMed ID: 7992823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
    Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
    Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.